Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 17%
Buy 50%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is a strong REIT with relatively high operator concentration and increasing RIDEA participation that could lead to upside or downside sensitivities, but their model includes a well-thought-out plan for redeployment of proceeds in order to drive growth, mitigate risk, and protect shareholder value. As such, investors may need to be patient in the short-term, but should see long-term value with increased exposure to Senior Housing and continued efforts to address conflicts of interest between NHI and NHC.

Bears say

National Health Investors is making a strategic decision to sell its entire portfolio of skilled nursing and independent living facilities to National HealthCare Corporation (NHC) for $560 million. While this will provide some short term financial benefits such as reduced debt and potential capital gains, it may not be the most advantageous long term decision for the company's growth and profitability. The company's decision to forgo higher rent increases and potential market resets with NHC in favor of focusing on its pipeline of higher quality senior housing assets could limit its potential for growth in the long term. Additionally, the sale may not have been as competitive as it could have been, potentially leaving some investors dissatisfied with the price. This may negatively impact the company's stock performance and potential for future acquisitions.

NHI has been analyzed by 6 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 50% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 6 analysts, NHI has a Buy consensus rating as of Sep 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $83.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $83.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.